Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma

NCT02579824 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class

Stopped stopped prematurely

Conditions

Interventions

Sponsor

M.D. Anderson Cancer Center

Collaborators